Track topics on Twitter Track topics that are important to you
(Reuters) - A U.S. judge has increased the amount medical device maker Zimmer Biomet Holdings Inc must pay Stryker Corp for infringing patents on a surgical cleaning wand to $248.7 million following a...
Product development and market expansion for Edwards and Medtronic, as bad news continues for Zimmer Biomet.Edwards Emerges Strong on FDA Nods, International ProspectZacks ($EW)Edwards Lifesciences' I...
OTTAWA (dpa-AFX) - NOVADAQ Technologies Inc. (NVDQ, NDQ.TO) announced a definitive arrangement with Stryker Corp. pursuant to which Stryker has agreed to acquire all of the issued and outstanding ...
The worldwide artificial disc market is expected to reach $4.8 billion by 2025 with Zimmer Biomet, DePuy Synthes, Stryker, Me -More-
Mary Brainerd has been elected to the board of directors of Stryker. -More-
Zimmer Biomet recently surprised with the announcement that CEO David Dvorak is immediately stepping down. -More-
Stryker ist vor allem für orthopädische und chirurgische Implantate bekannt, stellt aber darüber hinaus eine ganze Reihe anderer Hightech-Produkte für das Gesundheitswesen her - mit großartigem E...
In the field of dermatology, Zimmer MedizinSysteme GmbH, a company based in Neu-Ulm (southern Germany), has long been the global market leader for cryotherapy products. In founding the spin-off Zimmer...
Although single-radius (SR) designs of total knee replacement (TKR) have theoretical benefits, the clinical advantage conferred by such designs is unknown. The aim of this randomized, controlled study...
Although both clinical and biomechanical studies suggest that cephalomedullary implants have a mechanical advantage over extramedullary implants, a high rate of complications or implant failure remain...
To biomechanically compare a monocortical single frame external fixator (Orthofix UNYCO) with two bicortical fixator systems (dual frame: Stryker Hoffmann and single frame: Synthes LEF) with respect t...
Interstitial fluid pressure (IFP) in rats with breast cancer xenografts was non-invasively estimated using subharmonic-aided pressure estimation (SHAPE) versus an invasive pressure monitor. Moreover, ...
Rationale and design of the MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia in Subjects with Severe Peripheral Arterial Disease (MOBILE) trial investigating autologous bone marrow cell therapy for critical limb ischemia.
Critical limb ischemia (CLI) continues to place a significant encumbrance on patients and the health care system as it progresses to limb loss and long-term disability. Traditional methods of revascul...